New Paragraph
Users globally
Peer reviewed publications
Clinical pathways
Patient satisfaction
With our digital health solution, these people gain access to remote cardiac health assessments, thereby enabling early diagnosis and treatment. The data from these assessments supports healthcare providers in the clinical decision making, and makes clinical pathways more efficient.
With 98.3% sensitivity and 99.9% specificity in detecting AF, healthcare providers and patients feel confident in the possibilities of our technology.
PRESCRIBE FIBRICHECK
Controlled data flow
Prescribe FibriCheck on demand and ensure focused monitoring
Determine duration
Choose how long patients need to use FibriCheck and prevent the influx of unnecessary data
CLINICALLY VALIDATED MOBILE APP
Patients use their own device
Our smartphone app enables patients to conduct PPG recordings by placing their finger on the phone's camera
On-demand spot checks
Patients routinely perform 60s measurements at set times or when having symptoms, providing immediate actionable insights
HEALTHCARE PROVIDER PLATFORM
Implementation tailored to your needs
Integrate FibriCheck into your EMR and clinical workflow seamlessly
Effortless management and follow-up of your patients
Follow up on the heart rhythm of your patients and their aggregated results, manage patient groups and renew prescriptions easily
Patients
We provide patients with easy and affordable access to care and allow them to follow up on their own heart health for early detection and monitoring of heart conditions, which brings peace of mind.
Healthcare professionals
Our data supports healthcare providers in providing the correct diagnosis, making clinical decisions and monitoring of treatment effectiveness, while cutting back on costs, wait lists, time of in-hospital stay and workforce labor.
Payers and employers
With our technology, payers and employers can aim at preventative care, while guaranteeing clinical efficacy and safety. Guiding patients to the correct diagnosis, treatment, and post-treatment follow-up leads to cost savings and prevention of disease complications and recurrences.
And many more
The algorithm
Rivals that of state-of-the-art single and 6L-ECG devices, boasting over 98.3% sensitivity and 99.9% specificity in detecting AF
Regulatory clearances
FDA clearance
CE mark
ISO 13485:2016
IEC/ISO 27001:2013
HIPAA
Implemented in 20+ pathways
From detection and patient triaging to pre-and post treatment monitoring
Curious about how FibriCheck monitors patients to assess the success of procedures?
Download our detailed guide to uncover the methodologies and metrics that make FibriCheck a leader in health monitoring.
FibriCheck